Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145547 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring to Measure Effect of Glycemic Index
A NA study, sponsored by Legacy Health System.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01145547 is a NA study that has completed, run by Legacy Health System. The registered enrollment target is 7 participants.
The verdict
NCT01145547, a NA study, has completed, sponsored by Legacy Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Background: Post-prandial hyperglycemia is common in people with type 1 diabetes. Objective: The aim was to determine the impact of low vs high glycemic index (GI) on post-prandial glycemia for breakfast vs lunch and to quantify these effects with continuous glucose monitoring. Design: Seven adult subjects with type 1 diabetes participated in two experiments, each consisting of two meals each. In one experiment, both meals had a low GI; in the other, high GI. Meals were given 195 minutes apart and were matched for carbohydrate, protein, and fat content. Each subject received his usual pre-prandial insulin dosage, followed by a continuous subcutaneous basal insulin infusion for the remainder of the experiment. Arterialized venous glucose was analyzed every 15 minutes and sensor glucose was recorded every 5 minutes.
Interventions
- DEVICE Dexcom Seven® Plus Continuous Glucose Monitoring sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01145547
The ClinicalTrials.gov registry entry for NCT01145547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Seven® Plus Continuous Glucose Monitoring sensor is the first listed.
NCT01145547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01145547 about?
NCT01145547 is a clinical study titled "Continuous Glucose Monitoring to Measure Effect of Glycemic Index". Background: Post-prandial hyperglycemia is common in people with type 1 diabetes. Objective: The aim was to determine the impact of low vs high glycemic index (GI) on post-prandial glycemia for breakfast vs lunch and to quantify these effects with continuous glucose monitoring. Design: Seven adult...
What is the current status of trial NCT01145547?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2009-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT01145547?
The interventions under investigation include: Dexcom Seven® Plus Continuous Glucose Monitoring sensor (DEVICE).
Who is sponsoring clinical trial NCT01145547?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.